Nadia L Amin, MBChB, MSc, MA^1,2*, Sally Kinsey, MD, FRCP, FRCPath¹, Richard Feltbower, PhD, MSc, BSc^2*, Ajay J. Vora³, Nicholas Goulden, MD, PhD⁴, Rachel Wade, MSc^5*, Chris Mitchell, FRCPCH^6*, Rachael Hough, MD, BMBS, FRCP, FRCPath^7*, Clare Rowntree, PhD^8* and Beki James, PhD, MBChB, MA^1*

¹Leeds Children's Hospital, Leeds, United Kingdom
²University of Leeds, Leeds, United Kingdom
³Dept. of Pediatric Hematology, The Children's Hospital, Sheffield, United Kingdom
⁴Department of Haematology, Great Ormond Street Hospital For Children, London, United Kingdom
⁵CTSU, Oxford, United Kingdom
⁶John Radcliffe Hospital, Oxford, United Kingdom
⁷Cancer Institute, University College London, London, United Kingdom
⁸University Hospital of Wales, Cardiff, United Kingdom

Robert M. Rifkin^1,2, Eileen Fonseca, MS^3*, Yaozhu J. Chen, MPA^4*, Patricia S. Fox, MS^5*, James E. Browning, MPH^4* and Ze Cong^4*

¹US Oncology Research, The Woodlands, TX
²Rocky Mountain Cancer Centers, Denver, CO
³Health Economics and Outcomes Research, McKesson Specialty Health, The Woodlands, TX
⁴Onyx Pharmaceuticals, Inc., an Amgen subsidiary, South San Francisco, CA
⁵Research Services, McKesson Specialty Health, The Woodlands, TX

Charalampia Kyriakou, MD, PhD¹, Philip Murphy, MD^2*, Maria Teresa Petrucci, MD^3*, Pamela Bacon^4*, Philip Lewis^5*, Hélène Gilet, MSc^6*, Benoit Arnould, PhD^6*, Isabelle Vande Broek, MD, PhD^7* and Xavier Leleu, MD⁸

¹Department of Haematology, Royal Free and Northwick Park hospitals, London, United Kingdom
²Beaumont Hospital, Dublin, Ireland
³Division of Hematology, Department of Cellular Biotechnologies and Hematology, Sapienza University of Rome, Rome, Italy
⁴Celgene International Sàrl, Boudry, Switzerland
⁵Celgene GmbH, Munich, Germany
⁶Mapi, Lyon, France
⁷Iridium Kankernetwerk, Sint Niklaas, Belgium
⁸CHRU-Hôpital Claude Huriez, Lille, France

Xavier Leleu¹, Maria-Victoria Mateos², Michel Delforge³, Philip Lewis^4*, Thomas Schindler^4*, Craig Gibson^5*, Min Yang^6* and Katja C. Weisel^7*

¹CHRU-Hôpital Claude Huriez, Lille, France
²Hematology, Hospital Universitario de Salamanca, Salamanca, Spain
³University Hospital Leuven, Leuven, Belgium
⁴Celgene GmbH, Munich, Germany
⁵Celgene Corporation, Summit, NJ
⁶Analysis Group, Inc, Boston, MA
⁷Hematology & Oncology, Department of Medicine, University Hospital Tuebingen, Tuebingen, Germany

Kai Hübel, MD^1*, Nabih Azar, MD^2*, David Dunning, MD³, John Reitan, PharmD^4*, Meghan E. Gallagher, MSc^5* and Mohamad Mohty⁶

¹University Hospital of Cologne, Cologne, Germany
²Service d'Hématologie Clinique, Hôpital de la Pitié-Sâlpétrière, PARIS CEDEX 13, France
³VA Cancer Specialists, Fairfax, VA
⁴RJM Group LLC, Crown Point, IN
⁵Sanofi, Cambridge, MA
⁶Saint-Antoine Hospital and University Pierre & Marie Curie, Paris, France

Daphne Y Xiao, BA^1,2*, Katiuscia O'Brian, MA^1,3*, Suhong Luo, MPH^3,4* and Kenneth R Carson, MD^1,3,5

¹Research Service, St. Louis Veterans Affairs Medical Center, St. Louis, MO
²Washington University School of Medicine, St. Louis, MO
³Division of Oncology, Washington University School of Medicine, St. Louis, MO
⁴Research Service, St Louis Veterans Administration Medical Center, St. Louis, MO
⁵Division of Public Health Sciences, Washington University School of Medicine, St. Louis, MO

Gary H. Lyman, MD, MPH¹, Marek S. Poniewierski, MD, MS¹, Jeffrey Crawford, MD², David C. Dale, MD³ and Eva Culakova, PhD, MS¹

¹Hutchinson Institute for Cancer Outcomes Research, Fred Hutchinson Cancer Research Center, Seattle, WA
²Duke University, Durham, NC
³Department of Medicine, University of Washington, Seattle, WA

Nanxin Li^1*, Chelsey Yang^1*, Liangyi Fan^1*, Todor Totev^1*, Annie Guerin, MSc^2* and Lei Chen, MD, PhD^3*

¹Analysis Group, Inc., Boston, MA
²Analysis Group, Inc., Montreal, QC, Canada
³Novartis, East Hanover, NJ

Maximilian Schinke^1*, Inga Promny, MD^1*, Stefanie Hieke, PhD^2*, Johannes M. Waldschmidt, MD^1*, Gabriele Ihorst, PhD^3*, Milena Pantic, PhD^1*, Justus Duyster, MD^1*, Ralph Wäsch, MD, PhD^1*, Martin Schuhmacher, PhD.^2* and Monika Engelhardt, MD¹

¹Department of Hematology, Oncology and Stem Cell Transplantation, University of Freiburg Medical Center, Freiburg, Germany
²Institute of Medical Biometry and Medical Informatics, University Medical Center Freiburg, Freiburg, Germany
³Clinical Trials Unit, University of Freiburg Medical Center, Freiburg, Germany

Binay K. Shah, MD¹, Amir Bista, MD^2* and Sandhya Sharma, MBBS²

¹Cancer Center and Blood Institute, St. Joseph Regional Medical Center, Lewiston, ID
²Guthrie Robert Packer Hospital, Sayre, PA

Gordon Cook, MD, PhD¹, David Cella, PhD^2*, Brian Durie, MD³, Hartmut Goldschmidt, MD⁴, David Kuter, MD, DPhil⁵, Philippe Moreau^6*, Ravi Vij, MD, MBBS⁷, Catherine Davis^8*, Abderrahim Oukessou^8*, Teresa Zyczynski, PharmD, MPH, MBA, BSPharm^8*, Sergey Popov^9* and Antonio Palumbo, MD¹⁰

¹University of Leeds, Leeds, United Kingdom
²Northwestern University, Evanston, IL
³Cedars-Sinai Medical Center, Los Angeles, CA
⁴Heidelberg University Hospital, Heidelberg, Germany
⁵Massachusetts General Hospital Cancer Center, Boston, MA
⁶University Hospital, Nantes, France
⁷Washington University School of Medicine, St. Louis, MO
⁸Bristol-Myers Squibb, Princeton, NJ
⁹Parexel, St Petersburg, Russia
¹⁰A.O.U. San Giovanni Battista di Torino - Ospedale Molinette, Torino, Italy

Loretta A. Williams, PhD, APRN¹, Araceli Garcia-Gonzalez, MD, PhD^1*, Hycienth O. Ahaneku, MBBS, DrPH^2*, Jorge E. Cortes, MD³, Guillermo Garcia-Manero, MD⁴, Hagop M. Kantarjian, MD², Tito R. Mendoza, PhD^1*, Qiuling Shi, PhD^1*, Gautam Borthakur, MD², Jan A. Burger, MD^2*, Elias J. Jabbour, MD², Koichi Takahashi, MD², Huei K. Lin, MS^1*, Achala Limaye, BS^1* and Charles S. Cleeland, PhD^1*

¹Department of Symptom Research, The University of Texas MD Anderson Cancer Center, Houston, TX
²Department of Leukemia, The University of Texas MD Anderson Cancer Center, Houston, TX
³Department of Leukemia, University of Texas MD Anderson Cancer Center, Houston, TX
⁴Department of Leukemia, The University of Texas M.D. Anderson Cancer Center, Houston, TX, Houston, TX

Erlene Kuizon Seymour¹, Kamlai Saiya-Cork^1*, Brian Parkin², Kerby Shedden^3*, Jennifer Griggs^4* and Sami N. Malek²

¹University of Michigan, Ann Arbor, MI
²Department of Internal Medicine, Division of Hematology/Oncology, University of Michigan, Ann Arbor, MI
³Department of Statistics, University of Michigan, Ann Arbor, MI
⁴Internal Medicine; Hematology/Oncology, University of Michigan, Ann Arbor, MI

Christian Buske¹, Shalal Sadullah, FRCP, FRCPath^2*, Efsthatios Kastritis, MD^3*, Giulia Benevolo, MD^4*, Ramon Garcia-Sanz, MD^5*, Lukasz Bolkun, MD, PhD^6*, Xavier Leleu, MD, PhD⁷, Wolfgang Willenbacher, MD^8*, Roman Hajek, MD⁹, Ellen van der Spek, MD, PhD^10*, Mei Cheng, PhD^11*, Thorsten Graef, MD, PhD¹¹ and Meletios A. Dimopoulos, MD³

¹University of Ulm, Ulm, Germany
²James Pagent University Hospital, Norfolk, United Kingdom
³National and Kapodistrian University of Athens, Athens, Greece
⁴Division of Hematology, A.O.U. Citta della Salute e della Scienza di Torino, Torino, Italy
⁵Complejo Asistencial Universitario de Salamanca, Salamanca, Spain
⁶Medical University Hospital of Bialystok, Bialystok, Poland
⁷Maladies du Sang, Hôpital Claude Huriez, CHRU Lille, Lille, France
⁸Innsbruck Medical University, Innsbruck, Austria
⁹University Hospital of Ostrava, Ostrava, Czech Republic
¹⁰Rijnstate Hospital, Arnhem, Netherlands
¹¹Pharmacyclics LLC, an AbbVie Company, Sunnyvale, CA

Mohamed A. Kharfan-Dabaja, M.D.^1,2, Tea Reljic, MPH^3*, Jessica El-Asmar, M.D.^4*, Taiga Nishihori, M.D.^1,2, Ernesto Ayala, M.D.^1,2, Mehdi Hamadani, M.D.^5* and Ambuj Kumar, M.D., MPH^3*

¹Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL
²Dept. of Oncologic Sciences, University of South Florida, Morsani College of Medicine, Tampa, FL
³Center for Evidence-Based Medicine, University of South Florida, Morsani College of Medicine, Tampa, FL
⁴Dept. of Internal Medicine, American Univ. of Beirut, Beirut, Lebanon
⁵Dept. of Medicine, Medical College of Wisconsin, Milwaukee, WI

Pamela Skrabek, FRCPC¹, Oliver Bucher, MSc^2*, Matthew D. Seftel, MBChB, FRCP(C), MRCP¹ and Donna Turner, PhD^3*

¹Department of Medical Oncology/Hematology, CancerCare Manitoba, Winnipeg, MB, Canada
²Epidemiology & Cancer Registry, CancerCare Manitoba, Winnipeg, MB, Canada
³Population Oncology, CancerCare Manitoba, Winnipeg, MB, Canada

Fabio Efficace, PhD^1*, Gianluca Gaidano, MD, PhD², Massimo Breccia, MD^3*, Pasquale Niscola, MD^4*, Francesco Cottone^1*, Luana Fianchi^5*, Maria Teresa Voso^6*, Giovanni Caocci^7*, Francesco Buccisano⁶, Emanuele Angelucci, MD⁸, Valeria Santini, MD⁹, Reinhard Stauder, MD, MSc^10*, Uwe Platzbecker, MD¹¹, Alessandra Ricco, MD^12*, Nicola Di Renzo¹³, David Bowen, MD, PhD¹⁴ and Franco Mandelli, MD¹

¹Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy
²Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
³Dipartimento di Ematologia e Biotecnologie, Università La Sapienza, Rome, Italy
⁴Department of Hematology, “S. Eugenio Hospital”, Rome, Italy
⁵Institute of Hematology, Catholic University, Rome, Italy
⁶Hematology, University Tor Vergata, Rome, Italy
⁷Department of Medical Sciences, University of Cagliari, Cagliari, Italy
⁸Hematology and Transplant Center, Ospedale Oncologico di Riferimento Regionale, Cagliari, Italy
⁹AOU Careggi, University of Florence, Florence, Italy
¹⁰Department of Internal Medicine V (Hematology and Oncology), Innsbruck Medical University, Innsbruck, Austria
¹¹Medizinische Klinik und Poliklinik I, Universitätsklinikum Carl Gustav Carus, Dresden, Germany
¹²Department of Hematology, University of Bari, Bari, Italy
¹³Hematology, Vito Fazzi Hospital, Lecce, Italy
¹⁴St. James's Institute of Oncology, Leeds Teaching Hospitals, Leeds, United Kingdom

Joanna P. MacEwan, PhD^1*, Katharine Batt, MD, MSc², Wes Yin, PhD^3*, Desi Peneva, MS^1*, Steve Sison, MS^1*, Seanna Vine, MS^1*, Manan Shah, PhD^4* and Clara Chen, PhD, MS^4*

¹Precision Health Economics, Los Angeles, CA
²Wake Forest Baptist Medical Center, Winston-Salem, NC
³University of California Los Angeles, Los Angeles, CA
⁴Bristol-Myers Squibb, Plainsboro, NJ

Manali I. Patel, MD, MPH, MS¹, Norman Johnson, PhD^2*, Sean Altekruse, DVM, MPH, PhD^3* and Kim Rhoads, MD MPH^4*

¹Hematology/ Department of Medicine, Stanford University School of Medicine, Stanford, CA
²National Longitudinal Mortality Study, US Census Bureau, Bethesda, MD
³National Institute of Health, Bethesda, MD
⁴Stanford University School of Medicine, Stanford, CA

Heidi D. Klepin, MD, MS¹, Janet Tooze, PhD^2*, Timothy Pardee, MD, PhD¹, Leslie Renee Ellis, MD³, Dmitriy Berenzon, MD^4*, Dianna Howard, MD³, Wendy Demark-Wahnefried, PhD^5*, Shannon Mihalko, PhD^6*, William Jack Rejeski, PhD^6*, Bayard L. Powell, MD¹ and Stephen Kritchevsky, PhD^7*

¹Comprehensive Cancer Center, Wake Forest School of Medicine, Winston-Salem, NC
²Public Health Sciences, Wake Forest School of Medicine, WINSTON SALEM, NC
³Comprehensive Cancer Center, Wake Forest School of Medicine, Winston Salem, NC
⁴Comprehensive Cancer Center, Wake Forest School of Medicine, WINSTON SALEM, NC
⁵University of Alabama, Birmingham, AL
⁶Health and Exercise Science, Wake Forest University, WINSTON SALEM, NC
⁷Geriatrics and Gerontology, Wake Forest School of Medicine, WINSTON SALEM, NC

Kai Ruggeri, PhD^1,2*, Áine Maguire, MSc^2*, Susanne Schmitz, PhD^3*, Elisa Haller, MSc^2,4*, Cathal Walsh, PhD^5*, Jack Bowden, PhD^6*, Isla Kuhn^7*, Ayesha Khan, PhD^8*, Gordon Cook, MD, PhD⁹ and Michael O'Dwyer, MD¹⁰

¹Department of Psychology, University of Cambridge, Cambridge, United Kingdom
²Engineering Design Centre, University of Cambridge, Cambridge, United Kingdom
³Trinity College, Dublin, Dublin, Ireland
⁴Department of Psychology, University of Zurich, Zurich, Switzerland
⁵Department of Mathematics & Statistics, University of Limerick, Limerick, Ireland
⁶Biostatistics Unit, Medical Research Council, Cambridge, United Kingdom
⁷School of Clinical Medicine, University of Cambridge, Cambridge, United Kingdom
⁸Institute for NanoBioTechnology, Johns Hopkins University, Baltimore, MD
⁹University of Leeds, Leeds, United Kingdom
¹⁰Department of Haematology, University Hospital Galway, Galway, Ireland

Tanya Keenan, MD^1*, Thomas W. LeBlanc, MD, MA², Lara Traeger, PhD^1*, Harry Vandusen, BS^1*, Gregory A. Abel, MD, MPH³, David P. Steensma, MD³, Amir T. Fathi, MD⁴, Daniel J DeAngelo, MD, PhD⁵, Martha Wadleigh, MD⁵, Gabriela Hobbs, MD^6*, Philip C. Amrein, MD⁷, Richard M. Stone, MD⁸, Karen K. Ballen, MD¹, Yi-Bin Chen, MD¹, Jennifer S. Temel, MD^9* and Areej El-Jawahri, MD⁷

¹Massachusetts General Hospital, Boston, MA
²Duke Cancer Institute, Durham, NC
³Dana-Farber Cancer Institute, Boston, MA
⁴Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
⁵Dana Farber Cancer Institute, Boston, MA
⁶Massachusetts General Hospital / Dana Farber Harvard Cancer Center, Boston, MA
⁷Massachusetts General Hospital/Harvard Medical School, Boston, MA
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁹Hematology-Oncology, Massachusetts General Hospital, Boston, MA

Timothy A Quill, PhD^1*, Shaji K Kumar, MD², Suzanne Lentzsch³, Sagar Lonial, MD⁴, G. David Roodman, MD, PhD⁵, Erik D. Brady, PhD, CHCP^6*, Jim Mortimer^6*, Kevin L Obholz, PhD^6* and Kenneth C Anderson, MD⁷

¹CLINICAL CARE OPTIONS LLC, Reston, VA
²Division of Hematology, Mayo Clinic, Rochester, MN
³Division of Hematology/Oncology, Columbia University, New York, NY
⁴Winship Cancer Institute of Emory University, Department of Hematology and Medical Oncology, Atlanta, GA
⁵Medicine/Hematology-Oncology, Indiana University, Indianapolis, IN
⁶Clinical Care Options, LLC, Reston, VA
⁷The Jerome Lipper Multiple Myeloma Center, Dana-Farber Cancer Institute, Harvard Medical School, Boston, MA

Brady Stein, MD¹, Jerry L. Spivak, MD² and Alison R Moliterno, MD³

¹Dept. of Medicine, Division of Hematology/Oncology and Robert H. Lurie Comprehensive Cancer Center, Northwestern University Feinberg School of Medicine, Chicago, IL
²Division of Hematology, Johns Hopkins University School of Medicine, Baltimore, MD
³Division of Hematology, Department of Medicine, Johns Hopkins University School of Medicine, Baltimore, MD

Luis Alberto Rubio, BS^1*, David Banach, MD, MPH^2* and Alfred I Lee, MD, PhD³

¹Internal Medicine, Yale University School of Medicine, New Haven, CT
²Infectious Disease, Yale University School of Medicine, New Haven
³Hematology, Yale University School of Medicine, New Haven, CT

Louise Imlay-Gillespie, BMed^1*, Caroline Dix, MBBS^1*, Ashley McEwan, MD^1*, Kelly Wong^1*, Melanie Figtree, MBBS^2*, Christopher Arthur, MD¹, Luke Coyle, MBBS, FRACP, FRCPA³, Keith Fay, MBChB FRACP FRCPA¹, Matthew Greenwood, MBBS, FRACP, FRCPA^1*, Naomi Mackinlay, MBBS, FRACP, FRCPA^3*, Stephen Mulligan, MBBS, PhD, FRACP, FRCPA³, William Stevenson, MBBS, PhD¹, Christopher M Ward, MBChB, PhD, FRACP, FRCPA^1,4 and Ian H. Kerridge, MBBS, MPhil, FRACP, FRCPA^1*

¹Department of Haematology, Royal North Shore Hospital, Sydney, Australia
²Department of Microbiology and Infectious Diseases, Royal North Shore Hospital, Sydney, Australia
³Department of Haematology, Royal North Shore Hospital, St Leonards, Australia
⁴Kolling Institute of Medical Research, University of Sydney, Sydney, Australia

Binay K. Shah, MD¹, Amir Bista, MD^2* and Sandhya Sharma, MBBS²

¹Cancer Center and Blood Institute, St. Joseph Regional Medical Center, Lewiston, ID
²Guthrie Robert Packer Hospital, Sayre, PA

Gustavo Figueiredo Marcondes Westin, MD, MPH^1* and Ronald S. Go, MD^2,3

¹Hematology/Oncology, Mayo Clinic, Rochester, MN
²Division of Hematology, Mayo Clinic, Rochester, MN
³Robert D. and Patricia E. Kern Center for the Science of Health Care Delivery, Mayo Clinic, Rochester, MN

Pamela Blair Allen, MD¹, Mary Ellen Pavone, MD^2*, Kristin M Smith, R.N.^3*, Ralph Kazer, M.D.^4*, Alfred W Rademaker, Ph.D.^5*, Angela K Lawson, M.D.^6*, Molly Moravek, MD^7*, Rafael Confino Jr.^8*, Leo I. Gordon, MD⁹ and Jane N. Winter, MD¹⁰

¹Hematology/Oncology, Northwestern Memorial Hospital, Chicago, IL
²REI, Northwestern Memorial Hospital, Chicago
³Patient Navigator for Fertility Preservation, Northwestern Medical Group, Chicago, IL
⁴Obstetrics and Gynecology, Northwestern University/Division of Obstetrics and Gynecology-Reproductive Endo & Infertility, Chicago
⁵Northwestern University, Chicago
⁶Division of Obstetrics and Gynecology-Reproductive Endo & Infertility, Northwestern University, Chicago, IL
⁷Obstetrics and Gynecology/Department of Fertility, Northwestern University, Chicago, IL
⁸Northwestern University, Chicago, IL
⁹Northwestern University Feinberg School of Medicine, Division of Hematology/Oncology, Chicago, IL
¹⁰Department of Medicine-Hematology/Oncology, Feinberg School of Medicine, Northwestern University, Chicago, IL

Sara M. Tinsley, PhD, ARNP, AOCN^1*, Brent J Small, PhD^2*, Jeffrey E Lancet, M.D.³, Susan C McMillan, PhD, ARNP^4*, Rami S. Komrokji, MD⁵, Eric Padron, M.D.⁶, Kenneth S. Zuckerman, MD⁷ and Alan F. List, MD⁸

¹Malignant Hematology, H. Lee Moffitt Cancer Center & Research Institute, Tampa, FL
²Department Aging Studies, University of South Florida, Tampa, FL
³Malignant Hematology, H Lee Moffitt Cancer Center & Research Institute, Tampa, FL
⁴College of Nursing, University of South Florida, Tampa, FL
⁵H. Lee Moffitt Cancer Center, Tampa, FL
⁶Division of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL
⁷Moffitt Cancer Center and Research Insitute, Tampa, FL
⁸Department of Hematologic Malignancies, Moffitt Cancer Center and Research Institute, Tampa, FL

Asmita Mishra, M.D.¹, Binglin Yue^2*, Martine Extermann, MD, PhD³, Claudio Anasetti, MD¹, Heather Jim, PhD^4*, Jongphil Kim^2*, Joseph A Pidala, M.D., PhD¹ and Vickie E Baracos^5*

¹Blood and Marrow Transplantation, Moffitt Cancer Center, Tampa, FL
²Department of Biostatistics, Moffitt Cancer Center, Tampa, FL
³Senior Adult Oncology Program, H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁴H. Lee Moffitt Cancer Center and Research Institute, Tampa, FL
⁵Cross Cancer Institute, University of Alberta, Edmonton, AB, Canada

Samuel Lee, MD^1*, Michael Fallon^2*, Mary Mably, BPharm^2*, Jason Jared^2*, Daniel L Mulkerin^3*, Glenn Liu, MD^4* and Natalie Scott Callander, MD⁵

¹Department of Medicine, University of Wisconsin Hospital and Clinics, Madison, WI
²University of Wisconsin Hospital and Clinics, Madison, WI
³University of Wisconsin Carbone Comprehensive Cancer Center, Madison, WI
⁴University of Wisconsin Carbone Cancer Center, Ma
⁵University of Wisconsin Carbone Cancer Center, Madison, WI

Mark A Fiala, BS, CCRP^*, Michael Slade, BA^*, Jesse Keller, MD, Keith Stockerl-Goldstein, MD, Michael Tomasson, MD, Tanya M Wildes, MD, MSCI and Ravi Vij, MD, MBA

Department of Medicine, Division of Oncology, Washington University School of Medicine, Saint Louis, MO

Joanna P. MacEwan, PhD^1*, Katharine Batt, MD, MSc², Wes Yin, PhD^3*, Desi Peneva, MS^1*, Steve Sison, MS^1*, Seanna Vine, MS^1*, Manan Shah, PhD^4* and Clara Chen, PhD, MS^4*

¹Precision Health Economics, Los Angeles, CA
²Wake Forest Baptist Medical Center, Winston-Salem, NC
³University of California Los Angeles, Los Angeles, CA
⁴Bristol-Myers Squibb, Plainsboro, NJ

Amir Steinberg, MD¹, Janet H Van Cleave, PhD, RN^2*, Douglas Marks, MD^1*, Molly Lawson, BS, RN^1*, Antoinette Montelibano, BS, RN^1*, Amanda Philpott, BS, RN^1*, Kourtney Garner, BS, RN^1*, Eric So, BS^1*, Deirdre Ali, BS^1*, Erin Moshier, MS^1*, Marisa Cortese, PhD, RN^1* and Marilyn Hammer, PhD, RN^2*

¹Mount Sinai Medical Center, New York City, NY
²College of Nursing, New York University, New York City, NY

Lisi Huang^1*, Xin Du¹, Jianyu Weng, M.D.², Peilong Lai^1*, Zesheng Lu^1*, Ping Wu^1*, Suijing Wu, PhD^3*, Chengwei Luo^1*, Xin Huang^1* and Suxia Geng^1*

¹Department of Hematology, Guangdong General Hospital/Guangdong Academy of Medical Sciences, Guangzhou, China
²Department of Haematology, Guangdong General Hospital, Guangdong Academy of Medical Sciences, Guangzhou, China
³Department of Hematology, Guangdong General Hospital (Guangdong Academy of Medical Sciences), Guangzhou, China

Thomas W. LeBlanc, MD, MA^1,2, Laura J Fish, PhD^3*, Catherine T Bloom, MPH^4*, Areej El-Jawahri, MD⁵, Debra M Davis, RN, MSEd^6*, Susan C Locke, PhD^6* and Kathryn I Pollak, PhD^3*

¹Duke Cancer Institute, Durham, NC
²Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
³Program in Cancer Control and Population Sciences, Duke Cancer Institute, Durham, NC
⁴Duke Clinical Research Institute, Durham, NC
⁵Massachusetts General Hospital/Harvard Medical School, Boston, MA
⁶Center for Learning Health Care, Duke Clinical Research Institute, Durham, NC

Esther Natalie Oliva, MD¹, Prassede Salutari, MD^2*, Anna Candoni, MD^3*, Alessandra Freyrie, MD^4*, Debora Capelli, MD^5*, Francesco Di Raimondo⁶, Antonio Volpe, MD^7*, Nicola Cascavilla, MD^8*, Paolo Di Bartolomeo, MD², Erica Simeone, MD^9*, Agostino Cortelezzi, MD⁴, Pietro Leoni, Prof⁵, Pellegrino Musto, MD¹⁰, Fortunato Morabito, MD^11*, Pasquale Niscola, MD^12*, Natale Ranieri, MD^1*, Irene Santacaterina, MD^1*, Antonio Giovanni Marino, MD^1*, Patrizia Cufari^1*, Caterina Alati, MD^1* and Francesca Ronco^1*

¹Hematology, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy
²Dipartimento Ematologia, Ospedale Civile Santo Spirito, Pescara, Italy
³Hematology, Santa Maria della Misericordia University Hospital, Udine, Italy
⁴Oncohematology Unit, University of Milan, Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico, Milan, Italy
⁵Haematology Clinic, Ospedali Riuniti di Ancona, Ancona, Italy
⁶Department of Clinical and Molecular Biomedicine, University of Catania, Catania, Italy
⁷Hematology, S.Giuseppe Moscati Hospital, Avellino, Italy
⁸Hematology and BMT Unit, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
⁹Division of Hematology and Bone Marrow Transplantation, University Hospital, Udine, Italy
¹⁰Hematology, Centro di Riferimento Oncologico di Basilicata, Rionero in Vulture, Italy
¹¹Section of Hematology, A.O. L'Annunziata of Cosenza, Cosenza, Italy
¹²Department of Hematology, “S. Eugenio Hospital”, Rome, Italy

Erin L. Tomaszewski^1*, Catherine Fickley, PhD, MPH, CPH^2*, LeAnne Maddux, MA^3*, Robert Krupnick, PhD^4*, Erkut Bahceci, MD⁵, Jean Paty, PhD^6* and Floortje van Nooten, MSc^7*

¹Quintiles, Quintiles, New York
²Patient Centric Advisory Services, Quintiles, Pittsburgh
³Patient Centric Advisory Services, Quintiles, Cambridge
⁴Advisory Services, Quintiles, Cambridge, MA
⁵Astellas Pharma US, Inc., Northbrook, IL
⁶Advisory Services, Quintiles, New York
⁷Astellas/MA,G, HEOR, Astellas Pharma Europe BV, Leiden, Netherlands

Fabio Efficace, PhD^1*, Paola Fazi^2*, Cristina Santoro, MD^3*, Gianluca Gaidano, MD, PhD⁴, Francesco Cottone^1*, Alessandra Borchiellini^5*, Monica Carpenedo, MD^6*, Maria Pina Simula^7*, Valeria Di Giacomo^8*, Ivana Pierri, MD^9*, Francesco Nobile^10*, Francesco Rodeghiero¹¹, Laura Scaramucci^12*, Alessandro Rambaldi, MD¹³, Nicola Cascavilla, MD^14*, Fabio Forghieri^15*, Annamaria Petrungaro^16*, Paolo Ditonno^17*, Giorgio La Nasa^18*, Sonia Cirrincione^19*, Franco Mandelli, MD¹ and Maria Gabriella Mazzucconi, MD^20*

¹Italian Group for Adult Hematologic Diseases (GIMEMA), Data Center and Health Outcomes Research Unit, Rome, Italy
²GIMEMA Data Center, Rome, Italy
³University of Rome “Sapienza”, Department of Cellular Biotechnologies and Hematology, Rome, Italy
⁴Division of Hematology, Department of Translational Medicine, Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
⁵Hemostasis/Thrombosis Unit and Hemophilia Centre, Azienda Ospedaliera/Universitaria S. Giovanni Battista – Molinette, Turin, Italy
⁶Hematology and Transplant Unit, San Gerardo Hospital, Monza, Italy
⁷Hematology and Bone Marrow Transplantation Unit, Ospedale Oncologico di Riferimento Regionale Armando Businco, Cagliari, Italy
⁸Division of Hematology, Azienda Ospedaliera Papardo, Messina, Italy
⁹Hematology Clinic, IRCSS AOU S.Martino-IST, University of Genova, Genova, Italy
¹⁰Hematology, Azienda Ospedaliera Bianchi-Melacrino-Morelli,, Reggio Calabria, Italy
¹¹Department of Cell Therapy and Hematology, S. Bortolo Hospital, Vicenza, Italy
¹²Department of Haematology, S. Eugenio Hospital, Rome, Italy
¹³Ospedali Riuniti di Bergamo, Bergamo, Italy
¹⁴Hematology and BMT Unit, Casa Sollievo della Sofferenza, San Giovanni Rotondo, Italy
¹⁵Department of Oncology, Hematology and Respiratory Diseases, Section of Hematology, University of Modena and Reggio Emilia, Azienda Ospedaliero-Universitaria Policlinico, Modena, Italy
¹⁶Division of Hematology, University of Messina, Messina, Italy
¹⁷Hematology Unit, “Di Venere” Hospital, Bari, Italy
¹⁸Bone Marrow Transplant Center, R. Binaghi Hospital, Cagliari, Italy
¹⁹Unit of Transfusion and Hematology, Treviglio Hospital, Treviglio, Italy
²⁰Centro Regionale di Riferimento per l’Emofilia e Sindromi Correlate, Università Sapienza, Policlinico Umberto I, Rome, Italy

Yeon Joo Lee, MD, MPH^1,2*, Seong Jin Kim, MPH^1*, Daniel Burack, BS^1*, Yao-Ting Hayden Huang, PhD, MPH¹, Esperanza B Papadopoulos, MD^2,3, Ann A. Jakubowski, MD, PhD^2,3* and Genovefa A Papanicolaou, MD^1,2*

¹Infectious Disease Service, Department of Medicine, Memorial Sloan Kettering Cancer Center, New York, NY
²Weill Cornell Medical College, Cornell University, New York, NY
³Department of Medicine, Adult Bone Marrow Transplant Service, Memorial Sloan Kettering Cancer Center, New York, NY

Cherupolil R. Santhosh-Kumar, MD, Stephanie Struve, CSW^* and Sue Freier, CSW^*

Aurora Healthcare, Vince Lombardi Cancer Clinic, Sheboygan, WI

Sudeep Karve, PhD^1*, Victoria Divino, BA^2*, Andrew Gaughan, MSc^1*, Mitch DeKoven, MHSA^2*, Guozhi Gao^3* and Mark Lanasa, MD, PhD⁴

¹AstraZeneca, Gaithersburg, MD
²IMS Health, Fairfax, VA
³MedImmune, Gaithersburg, MD
⁴Clinical Development, Oncology, MedImmune, Gaithersburg, MD

Areej El-Jawahri, MD¹, Sean F. Heavey, BS^2*, Thomas W. LeBlanc, MD, MA³, Harry Vandusen, BS^4*, Gregory Abel, MD, MPH⁵, David P. Steensma, MD⁶, Lara Traeger, PhD^4*, Amir T. Fathi, MD⁷, Daniel J. DeAngelo, MD, PhD⁸, Martha Wadleigh, MD⁶, Gabriela Hobbs, MD^9*, Philip C. Amrein, MD¹, Richard M. Stone, MD⁸, Karen K. Ballen, MD⁴, Yi-Bin Chen, MD⁴ and Jennifer S. Temel, MD^2*

¹Massachusetts General Hospital/Harvard Medical School, Boston, MA
²Hematology-Oncology, Massachusetts General Hospital, Boston, MA
³Division of Hematologic Malignancies and Cellular Therapy, Duke University School of Medicine, Durham, NC
⁴Massachusetts General Hospital, Boston, MA
⁵Dana-Farber Cancer Inst., Boston, MA
⁶Dana-Farber Cancer Institute, Boston, MA
⁷Massachusetts General Hospital Cancer Center, Harvard Medical School, Boston, MA
⁸Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA
⁹Massachusetts General Hospital / Dana Farber Harvard Cancer Center, Boston, MA

Christopher Pleyer, MD¹, Amber Afzal, MD^2*, William Shomali, MD^1*, Paul Elson, PhD^3*, Jia Xuefei^4*, Suzanne Bakdash, MD, MPH⁵, Anjali S. Advani, MD⁶, Aaron T. Gerds, MD, MS⁶, Hetty E. Carraway, MD, MBA⁶, Matt Kalaycio, MD⁷, Jaroslaw P. Maciejewski, MD, Ph.D.⁸, Mikkael A. Sekeres, MD, MS⁶ and Sudipto Mukherjee, MD, PhD⁶

¹Department of Internal Medicine, Cleveland Clinic, Cleveland, OH
²Internal Medicine, Cleveland Clinic Foundation, Cleveland, OH
³Cleveland Clinic, Quantitative Health Sciences, Cleveland, OH
⁴Quantitative Health Sciences, , Cleveland Clinic, Ohio
⁵Department of Clinical Pathology, Cleveland Clinic, Cleveland, OH
⁶Leukemia Program, Cleveland Clinic, Cleveland, OH
⁷Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH
⁸Translational Hematology and Oncology Research, Taussig Cancer Institute, Cleveland Clinic, Cleveland, OH